A detailed history of Northeast Financial Consultants Inc transactions in Pfizer Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 1,207,994 shares of PFE stock, worth $31.8 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
1,207,994
Previous 1,196,768 0.94%
Holding current value
$31.8 Million
Previous $33.5 Million 4.4%
% of portfolio
1.55%
Previous 1.55%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $310,960 - $352,384
11,226 Added 0.94%
1,207,994 $35 Million
Q2 2024

Aug 15, 2024

SELL
$25.26 - $29.6 $1.17 Million - $1.37 Million
-46,391 Reduced 3.73%
1,196,768 $33.5 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $36.6 Million - $42 Million
-1,413,451 Reduced 53.21%
1,243,159 $34.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $5.39 Million - $7 Million
206,107 Added 8.41%
2,656,610 $76.5 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $6.16 Million - $7.2 Million
-191,848 Reduced 7.26%
2,450,503 $81.3 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $18,565 - $21,480
-514 Reduced 0.02%
2,642,351 $96.9 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $27.4 Million - $35.6 Million
694,566 Added 35.65%
2,642,865 $108 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1.93 Million - $2.52 Million
46,227 Added 2.43%
1,948,299 $99.9 Million
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $2.47 Million - $3.01 Million
-56,350 Reduced 2.88%
1,902,072 $83.2 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $620,989 - $736,298
-13,346 Reduced 0.68%
1,958,422 $103 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $17.5 Million - $21.7 Million
383,242 Added 24.13%
1,971,768 $102 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $545,176 - $808,132
-13,194 Reduced 0.82%
1,588,526 $93.8 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $264,741 - $340,082
-6,745 Reduced 0.42%
1,601,720 $68.9 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $11.1 Million - $12.5 Million
307,977 Added 23.68%
1,608,465 $63 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $277,598 - $313,075
8,289 Added 0.64%
1,300,488 $47.1 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $51.5 Million - $65.5 Million
-1,539,372 Reduced 54.36%
1,292,199 $47.6 Million
Q3 2020

Oct 29, 2020

BUY
$31.75 - $37.25 $2.01 Million - $2.36 Million
63,399 Added 2.29%
2,831,571 $104 Million
Q2 2020

Jul 30, 2020

BUY
$30.12 - $36.54 $565,924 - $686,550
18,789 Added 0.68%
2,768,172 $91.5 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $8.84 Million - $12.6 Million
327,189 Added 13.51%
2,749,383 $89.7 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $26.4 Million - $30 Million
801,923 Added 49.49%
2,422,194 $94.9 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $25.2 Million - $32.7 Million
-775,616 Reduced 32.37%
1,620,271 $58.2 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $78,656 - $88,313
2,127 Added 0.09%
2,395,887 $104 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $847,125 - $930,708
-22,590 Reduced 0.93%
2,393,760 $102 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $78.2 Million - $89.2 Million
2,034,004 Added 531.98%
2,416,350 $105 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $32.5 Million - $39.4 Million
-943,371 Reduced 71.16%
382,346 $16.8 Million
Q2 2018

Jul 27, 2018

SELL
$32.98 - $35.16 $29,681 - $31,643
-900 Reduced 0.07%
1,325,717 $48.1 Million
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $140,084 - $162,517
-4,390 Reduced 0.33%
1,326,617 $47.1 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $610,221 - $647,465
18,347 Added 1.4%
1,331,007 $48.2 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $40.7 Million - $44.8 Million
1,312,660
1,312,660 $46.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.